1,157
Views
15
CrossRef citations to date
0
Altmetric
Research Article

EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7

, , , &
Pages 1067-1075 | Received 27 May 2018, Accepted 13 Sep 2018, Published online: 14 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pedro Gonzalez-Cruz & Harvinder Singh Gill. (2021) Demystifying particle-based oral vaccines. Expert Opinion on Drug Delivery 18:10, pages 1455-1472.
Read now

Articles from other publishers (14)

Zoila Gándara, Noelia Rubio & Rafael R. Castillo. (2023) Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems. Pharmaceutics 15:2, pages 351.
Crossref
Hossein Samiei, Shahram Nazarian, Abass Hajizade & Emad Kordbacheh. (2023) In silico design, production and immunization evaluation of a recombinant bivalent fusion protein candidate vaccine against E. coli O157:H7. International Immunopharmacology 114, pages 109464.
Crossref
Stuti Bhagat, Divya Mehta & Sanjay Singh. 2023. Nanomaterials. Nanomaterials 329 361 .
Mohammad Harun-Ur-Rashid, Israt Jahan & Abu Bin Imran. 2023. Nanovaccinology. Nanovaccinology 135 160 .
Guihong Pen, Na Yang, Da Teng, Ya Hao, Ruoyu Mao & Jianhua Wang. (2022) The Outer Membrane Proteins and Their Synergy Triggered the Protective Effects against Pathogenic Escherichia coli. Microorganisms 10:5, pages 982.
Crossref
Yating Gao, Yue Zhang, Yanlong Hong, Fei Wu, Lan Shen, Youjie Wang & Xiao Lin. (2022) Multifunctional Role of Silica in Pharmaceutical Formulations. AAPS PharmSciTech 23:4.
Crossref
Parastou Rahimizadeh, Zahra Rezaieyazdi, Faezeh Behzadi, Abbas Hajizade & Sung In Lim. (2021) Nanotechnology as a promising platform for rheumatoid arthritis management: Diagnosis, treatment, and treatment monitoring. International Journal of Pharmaceutics 609, pages 121137.
Crossref
Zakieh Sadat Hoseini, Abbas Hajizade, Jamshid Razmyar, Gholamreza Ahmadian & Ayyoob Arpanaei. (2021) Mesoporous silica nanoparticles-based formulations of a chimeric proteinous vaccine candidate against necrotic enteritis disease. Materials Science and Engineering: C 128, pages 112316.
Crossref
Carlos Angulo, Marlene Tello‐Olea, Martha Reyes‐Becerril, Elizabeth Monreal‐Escalante, Luis Hernández‐Adame, Miriam Angulo & José M. Mazon‐Suastegui. (2020) Developing oral nanovaccines for fish: a modern trend to fight infectious diseases. Reviews in Aquaculture 13:3, pages 1172-1192.
Crossref
Melibea Berzosa, Yadira Pastor, Juan M. Irache & Carlos Gamazo. 2021. Applications of Nanobiotechnology for Neglected Tropical Diseases. Applications of Nanobiotechnology for Neglected Tropical Diseases 3 27 .
Muhammad Mustafa Abeer, Prarthana Rewatkar, Zhi Qu, Meghna Talekar, Freddy Kleitz, Roman Schmid, Mika Lindén, Tushar Kumeria & Amirali Popat. (2020) Silica nanoparticles: A promising platform for enhanced oral delivery of macromolecules. Journal of Controlled Release 326, pages 544-555.
Crossref
Rafael R. Castillo, Daniel Lozano & María Vallet-Regí. (2020) Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules. Pharmaceutics 12:5, pages 432.
Crossref
Emad Kordbacheh, Shahram Nazarian, Abbas Hajizade & Amin Farhang. (2019) Entrapment of HETS recombinant protein onto PLGA and alginate NPs improves the immunogenicity of the protein against E. coli O157:H7. Molecular Immunology 114, pages 612-619.
Crossref
Sergio Rosales-Mendoza & Omar González-OrtegaSergio Rosales-Mendoza & Omar González-Ortega. 2019. Nanovaccines. Nanovaccines 105 130 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.